Skip to content

Contralateral Study of WaveLight® Femtosecond Laser Devices for Corneal Flap Creation

Contralateral Study of the WaveLight® Ultraviolet Femtosecond Laser, Model 1026 Versus the WaveLight® FS200 Infrared Femtosecond Laser, Model 1025 for Corneal Flap Creation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06021353
Enrollment
47
Registered
2023-09-01
Start date
2023-10-20
Completion date
2024-12-12
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Errors

Brief summary

The purpose of this study is to assess the WaveLight Ultraviolet Femtosecond Laser System, Model 1026 (UV fs-Laser) corneal flap creation accuracy as compared to the already marketed WaveLight FS200 Infrared Femtosecond Laser, Model 1025 (IR fs-Laser).

Detailed description

Subjects who qualify to participate will have both eyes treated in the study (one eye with the UV fs-Laser and the other eye with the IR fs-Laser) and will attend a total of 5 study visits over a period of approximately 2 months. This study will be conducted outside the United States.

Interventions

Stationary scanning spot femtosecond laser used for corneal flap creation during refractive surgery

Stationary scanning spot femtosecond laser used for corneal flap creation during refractive surgery

PROCEDURELASIK

Laser-assisted in situ keratomileusis (LASIK) surgery

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Good ocular health; * Natural lens with no evidence of cataract; * Eligible for LASIK; * Stable refraction; * Other protocol-defined inclusion criteria may apply. Key

Exclusion criteria

* Presence of dry eye; * Contraindicated systemic disease or ocular conditions; * Treatment with a contraindicated medication; * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Maximum deviation of corneal flap thickness at the margins from achieved central flap thickness at 1 monthMonth 1Corneal flap thickness will be measured using optical coherence tomography (OCT)

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026